Teva Pharmaceutical Industries Limited Cash Flow-to-Debt Ratio
Teva Pharmaceutical Industries Limited cash flow-to-debt ratio. Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of €-40.00 Million could theoretically repay 0% of its total liabilities (€31.81 Billion) in one year. Check how high is Teva Pharmaceutical Industries Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Teva Pharmaceutical Industries Limited (2015–2025)
Cash flow-to-debt ratio of Teva Pharmaceutical Industries Limited from 2015 to 2025. Historical debt coverage capacity for Teva Pharmaceutical Industries Limited across 11 annual periods. Check Teva Pharmaceutical Industries Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Teva Pharmaceutical Industries Limited Cash Flow-to-Debt Ratio by Year (2015–2025)
Teva Pharmaceutical Industries Limited cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Teva Pharmaceutical Industries Limited. For the full cash flow conversion analysis, see TEV cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | €1.65 Billion | €32.83 Billion | ▲ +35.3% |
| 2024 | 0.04x | €1.25 Billion | €33.61 Billion | ▲ +13.4% |
| 2023 | 0.03x | €1.16 Billion | €35.35 Billion | ▼ -27.3% |
| 2022 | 0.05x | €1.59 Billion | €35.31 Billion | ▲ +105.5% |
| 2021 | 0.02x | €798.00 Million | €36.42 Billion | ▼ -28.7% |
| 2020 | 0.03x | €1.22 Billion | €39.58 Billion | ▲ +74.2% |
| 2019 | 0.02x | €748.00 Million | €42.41 Billion | ▼ -67.6% |
| 2018 | 0.05x | €2.45 Billion | €44.89 Billion | ▲ +27.0% |
| 2017 | 0.04x | €2.23 Billion | €51.87 Billion | ▼ -36.2% |
| 2016 | 0.07x | €3.89 Billion | €57.90 Billion | ▼ -70.5% |
| 2015 | 0.23x | €5.54 Billion | €24.31 Billion | — |